Yahoo India Web Search

  1. Ad

    related to: Dr. Reddy's Laboratories
  2. Easily Find Medication At Affordable Prices. Amazon Offers an Array Of Unique Products From Hundreds Of Brands.

Search results

  1. Dr. Reddys is a multinational company that provides access to affordable and innovative medicines and healthcare solutions. It operates in various businesses, such as API, generics, biosimilars and digital healthcare, and serves over half a billion patients worldwide.

  2. Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] . Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.

  3. Learn about Dr. Reddys Laboratories, a trusted name in the Indian healthcare industry since 1986. Explore its portfolio of over 200 products across therapy areas, its robust field force and inventory management system, and its Purple Health initiative to address patient needs.

  4. Learn about Dr. Reddy's, a global pharmaceutical company based in India, and its products, markets, sustainability goals and latest updates. Follow the company on LinkedIn to connect with its employees and partners.

  5. 15 hours ago · Shares of Dr Reddy's Labs have surged about 3 per cent to Rs 6417.95 during the trading session on Friday, commanding a total market capitalization of close to Rs 1.10 lakh crore.

  6. 21 hours ago · Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Dr. Reddy's Laboratories, including: Last traded price 6255.45, Market capitalization: 104026.2, Volume: 1250, Price-to-earnings ratio 18.65, Earnings per share 334.37.

  7. People also ask

  8. May 7, 2024 · Dr Reddy's Laboratories on Tuesday reported a consolidated net profit of Rs 1,307 crore for the quarter ended March 31, 2024, which was up by 36% on a year-on-year (YoY) basis while down by 5% on a sequential basis. The profit figure beat ET Now poll estimate of Rs 1,290 crore.

  1. People also search for